Advertisement

Psychopharmacologia

, Volume 7, Issue 4, pp 303–310 | Cite as

Effects of imipramine on anxiety and hostility levels

  • Louis A. Gottschalk
  • Goldine C. Gleser
  • Harold W. WylieJr.
  • Stanley M. Kaplan
Short Communications

Summary

  1. 1.

    An initial longitudinal study of the psychologic effects of imipramine on one patient in which the active drug was alternated with a placebo, led to short term studies on four other subjects. A measure of emotional reaction was used which was derived from small samples of speech; it was demonstrated to be an objective and sensitive instrument for the detection of changes in anxiety and hostility.

     
  2. 2.

    While imipramine was consistently associated with an increase in the expression of hostility directed outward for the one patient, the increase in hostility outwards for four additional patients was not sufficiently great to reject, with conviction, the hypothesis of chance. However, these four other patients did show a significant increase in a subcategory of hostility directed outward, namely, overt hostility outward.

     
  3. 3.

    Imipramine, as compared to a placebo, significantly increased levels of anxiety in the verbal samples of the subjects tested.

     
  4. 4.

    No significant changes were noted with imipramine on scores of hostility directed inwards or ambivalently directed hostility, probably because none of these patients was clinically depressed.

     

Keywords

Placebo Longitudinal Study Active Drug Imipramine Emotional Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Akimoto, H., M. Natatuk, and Y. Machiyama: Clinical experience with MAO inhibitors. Dis. nerv. Syst. 21, 645–648 (1960).PubMedGoogle Scholar
  2. Azima, H., and R. H. Vispo: Effects of imipramine (Tofranil) on depressive states: A clinical and psychodynamic study. Arch. Neurol. Psychiat. 81, 658–664 (1959).Google Scholar
  3. Blair, D.: Treatment of severe depression by imipramine (Tofranil): An investigation of 100 cases. J. ment. Sci. 106, 891–905 (1960).Google Scholar
  4. Chassan, J. B.: Stochastic models of the single case in clinical research design. Behav. Sci. 6, 42–50 (1961).PubMedGoogle Scholar
  5. Chassan, J. B., and L. Bellak: An introduction to intensive design in the evaluation of drug efficacy in psychotherapy. In: Methods of Research in Psychotherapy. Gottschalk, L. A., and A. H. Auerbach (eds.). New York: Appleton-Century-Crofts 1965.Google Scholar
  6. Gleser, G. C., L. A. Gottschalk, and K. J. Springer: An anxiety scale applicable to verbal samples. Arch. gen. Psychiat. 5, 593–605 (1961).PubMedGoogle Scholar
  7. - - and R. Fox: Immediate changes in anxiety and hostility with chlordiazepoxide administration in juvenile delinquent boys. (In preparation) (1965).Google Scholar
  8. Gottschalk, L. A., F. T. Kapp, W. D. Ross, S. M. Kaplan, H. Silver, J. H. MacLeod, J. B. Kahn, E. F. Van Maanen and G. H. Acheson: Explorations in testing drugs affecting physical and mental activity. J. Amer. med. Ass. 161, 1054–1058 (1956).Google Scholar
  9. —, G. C. Gleser, R. A. Daniels, and S. C. Block: The speech patterns of schizophrenic patients: A method of assessing relative degree of personal disorganization and social alienation. J. nerv. ment. Dis. 127, 153–166 (1958a).PubMedGoogle Scholar
  10. —, and S. M. Kaplan: A quantitative method of estimating variations in intensity of a psychologic conflict or state. Arch. Neurol. Psychiat. (Chic.) 79, 688–696 (1958b).Google Scholar
  11. —, G. C. Gleser, K. J. Springer, S. Kaplan, J. Shanon, and W. D. Ross: The effects of perphenazine on verbal behavior: A contribution to the problem of measuring the psychologic effect of psychoactive drugs. Arch. gen. Psychiat. 2, 632–639 (1960).PubMedGoogle Scholar
  12. —, K. J. Springer, and G. C. Gleser: Experiments with a method of assessing the variations in intensity of certain psychological states occurring during two psychotherapeutic interviews. In: Comparative Psycholinguistic Analysis of Two Psychotherapeutic Interviews. Edited by Gottschalk, L. A. New York: International Universities Press 1961a.Google Scholar
  13. —, G. C. Gleser, E. B. Magliocco, and T. D'Zmura: Further studies on the speech patterns of schizophrenic patients: Measuring inter-individual differences. J. nerv. ment. Dis. 132, 101–113 (1961b).PubMedGoogle Scholar
  14. — —, and K. J. Springer: Three hostility scales applicable to verbal samples. Arch. gen. Psychiat. 9, 254–279 (1963).PubMedGoogle Scholar
  15. — —, T. D'Zmura, and I. B. Hanenson: Some psychophysiological relationships in hypertensive women: The effect of hydrochlorothiazide on the relation of affect to blood pressure. Psychosom. Med. 26, 610–617 (1964a).PubMedGoogle Scholar
  16. — —, Distinguishing characteristics of the verbal communications of schizophrenic patients. Proceedings of the Assn. for Research in Nerv. and Ment. Dis. on Disorders of Communication. Baltimore: Williams and Wilkins Co. 1964b.Google Scholar
  17. Lehmann, H. E.: New drugs in psychiatric therapy. Canad. med. Ass. J. 85, 1145–1151 (1961).PubMedGoogle Scholar
  18. Pollack, B.: Clinical findings in the case of Tofranil in depressive and other psychiatric states. Amer. J. Psychiat. 116, 312–317 (1959).PubMedGoogle Scholar
  19. Ross, W. D., N. Adsett, G. C. Gleser, C. R. B. Joyce, S. M. Kaplan, and M. E. Tieger: A trial of psychopharmacologic measurement with projective techniques. J. project. techn. 27, 222–225 (1963).PubMedGoogle Scholar
  20. Ruskin, D., and R. D. Goldner: Treatment of depressions in private practice with imipramine. Dis. nerv. Syst. 20, 391–399 (1959).Google Scholar
  21. Whitman, R. M., M. Pierce, J. W. Maas, and B. Baldridge: Drugs and dreamsII: Imipramine and prochlorperazine. Comprehens. Psychiat. 2, 219–226 (1961).Google Scholar

Copyright information

© Springer-Verlag 1965

Authors and Affiliations

  • Louis A. Gottschalk
    • 1
    • 2
  • Goldine C. Gleser
    • 1
    • 2
  • Harold W. WylieJr.
    • 1
    • 2
  • Stanley M. Kaplan
    • 1
    • 2
  1. 1.Psychosomatic Service, Department of PsychiatryUniversity of Cincinnati College of Medicine, the Cincinnati General HospitalUSA
  2. 2.Cincinnati Veterans Administration, and the Mental Health Study Center NIMHAdelphi

Personalised recommendations